Navigation Links
HealthEdge(R) Presents Award-Winning HealthRules(R) Technology Platform at the 2008 Gartner Healthcare Summit
Date:11/13/2008

Revolutionary HealthRules software suite enables payors to compete like

never before in the rapidly evolving healthcare marketplace

BURLINGTON, Mass., Nov. 13 /PRNewswire/ -- HealthEdge, provider of the only modern, enterprise-class software platform for healthcare payors, today announced that it will showcase its patented, award-winning HealthRules software suite at the 2008 Gartner Healthcare Summit. The conference will be held on November 16-19 at the San Diego Sheraton Hotel and Marina. HealthEdge will offer its business case "Solving 21st Century Healthcare Challenges using 21st century technology".

"Payor organizations must address the business imperatives that are shaping the new healthcare economy," said Rob Gillette, CEO of HealthEdge. "HealthRules is the only solution that was truly built with these next-generation needs in mind. We look forward to sharing our story with the diverse group of healthcare executives that will be attending this year's summit."

The HealthRules product suite includes next-generation claims and benefit administration, business intelligence and portal solutions that were designed to help transform today's payor organizations into tomorrow's healthcare leaders.

Built on a modern technology platform and delivered by a company that has become known for rapid innovation, HealthRules brings agility to organizations pursuing a competitive position in the dynamic new healthcare marketplace.

About HealthEdge

HealthEdge provides the only modern, enterprise-class software platform for healthcare payors. Using the patented HealthRules(R) software suite, health plans, health insurance companies and other payors can finally respond to new business opportunities and market changes in hours, not months or years, while drastically reducing both IT and operational costs. Leveraging an investment of over $125 million in information technology, HealthRules is the most modern, scalable and cost
'/>"/>

SOURCE HealthEdge
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Hearing Loss Presents a Significant Challenge for Rising Number of Caregivers
2. How America Signs Her Name; United Spinal Association Presents How to Display Our Flag
3. Tibotec presents interim findings for TMC435, an investigational genotype 1 hepatitis C treatment
4. Topical treatment for cold sores achieves efficacy of oral drugs; represents paradigm shift
5. Access Pharmaceuticals Presents ProLindac(TM) Data at the AACR-NCI-EORTC Symposium 2008
6. NeoVista Presents Anatomic Outcomes of Novel Wet AMD Therapy at 2008 American Society of Retina Specialists Meeting
7. Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer
8. The Lewin Group Presents McCain and Obama Health Policies: Cost and Coverage Compared Analysis
9. Stater Bros. Markets Presents $1,143,000 Check to Muscular Dystrophy Association
10. Curemark CEO Presents Autism Findings at Prestigious Neurobiology Conference at Oxford
11. AMA Foundation Presents the Arthur N. Wilson, MD Scholarship to Promising Medical Student From Southeast Alaska

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...UILLY-SUR-SEINE,France,Nov.27/PRNewswire/--TeamGar...teamdedicatedtoethicalsportinganddevelopingthenext...illbecomeTeamGarmin-TransitionswiththeadditionofTr...Opticalistheworld,sleadingmanufacturerofadaptiveey...yinthewidestselectionofspectaclelensessuchasTransi...
(Date:11/27/2009)... XenaCare Holdings has announced th...is Foundation, one of the largest nonprofit organi... health education. , Delr... Holdings, Inc. (OTCBB: XCHO), a company specializ...nsumer healthcare products, has announced today th...
(Date:11/27/2009)...tes to bring unprecedented medical, economic burde...HealthDay News) -- The number of people with diabe...r the next 25 years, a new study predicts. , Th...lion people with the disease, up from 23.7 million...ng people with diabetes will triple, the study als...
(Date:11/27/2009)... Voyant Health™ announced tod...as licensed its TraumaCad Enterprise orthopedic te...w solution. , (PRWEB) Nov...oday that Spectrum Health (Grand Rapids, Michigan)...templating solution and its TraumaCad Extend workf...
(Date:11/27/2009)... Specialist manufacturers who use m...re saving millions of dollars by bringing in techn... Increasing numbers of pro-active medical manufact...the concept stage of their projects, ensuring that...gn processes or potentially outdated technology. ...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
...nsula Medical School in the South West of England ...eel that doctors providing out of hours services i... Researchers held group discussions and carried ou...ngland. , Under the GP contract, which came into ...
... 29 CalbaTech, Inc.,(OTC Bulletin Board: CLBE), a...aTech.com ) concentrating on the collection and ba...apeutic uses and providing,products and platforms ...th has renewed LifeStem,s biologics license.,LifeS...
...Role as Governments and Civil Society in the ...Crisis, NEW DELHI, India, BEIJING and BANGKOK, Th...IDS Day 2007, hundreds, perhaps thousands, of men,...but ever-growing crisis that many governments in t...
...the hip is a growing problem that will continue to... have reported on risk factors for developing OA, ...ct its prognosis. A new study published in the Dec...r disease progression and to find out how many und...
...it has obtained agreement with the United States, ...n of its pivotal study, protocol for SP1049C for t... upper gastrointestinal tract, ...rsus BSC alone for the treatment of patients with ...
...) -- There are estimated to be between 50,000 --...ronic Immune Thrombocytopenic Purpura (ITP), an au...ber of platelets in their blood -- causing bruises...rk-Presbyterian Hospital/Weill Cornell Medical Cen...
Other Medicine News:Health News:Out of hours doctors reluctant to do home visits, say patients 2Health News:CalbaTech Reports That LifeStem's Biologics License Has Been Renewed 2Health News:CalbaTech Reports That LifeStem's Biologics License Has Been Renewed 3Health News:New Asia Pacific Statistics Reveal an Alarming Incidence of HIV in MSM 2Health News:New Asia Pacific Statistics Reveal an Alarming Incidence of HIV in MSM 3Health News:New Asia Pacific Statistics Reveal an Alarming Incidence of HIV in MSM 4Health News:New Asia Pacific Statistics Reveal an Alarming Incidence of HIV in MSM 5Health News:New Asia Pacific Statistics Reveal an Alarming Incidence of HIV in MSM 6Health News:Identifying patients at high risk for total hip replacement 2Health News:Supratek Pharma Inc. announced today that under the Special Protocol 2Health News:Eltrombopag studied in Idiopathic Thrombocytopenic Purpura 2
(Date:11/25/2009)...wire-FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),amed...imallydisruptivesurgicaltreatmentsforthespine,anno...vember30,2009,at5:30p.m.ET/2:30p.m.PT.Theconferenc...ntfortheCompany,sproductsandwillincludecommentsfro...n.Thedial-innumbersare1-877-407-4018fordomesticcal...
(Date:11/25/2009)...dJOHANNESBURG,November25/PRNewswire/--,iThembaPhar...cedtoday,thattheyhavesignedacollaborativeagreement...is,sworldclasscomputationalchemistryandleaddiscove...iontoprovidemedicinaland,syntheticchemistrysupport...entnetwork.iThembaPharmaceuticalsandPyxisDiscovery...
(Date:11/24/2009)...wswire/-- ,, WHAT:RomHoubens,aBelgianmanthought...wasactuallyfullyconsciousandawakeduringthattimeand...oxEyeMaxwasfeaturedinthesegmenttoillustratehowpeop...communication. ,, WHEN:GoodMorningAmerica-- Tue...ch.com ,, WHO:RomHoubenswasanengineeringstu...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2FDA Approves NovoLog 28R 29 Labeling Update 51814 1FDA Approves NovoLog 28R 29 Labeling Update 51814 2FDA Approves NovoLog 28R 29 Labeling Update 51814 3FDA Approves NovoLog 28R 29 Labeling Update 51814 4U S Students Academic Interests Tend to Wane in Middle School 51812 1U S Students Academic Interests Tend to Wane in Middle School 51812 2Michael Steele Chairman of the Republican National Committee Will Hold a Press Conference on Health Care the Republican Alternative at 9 am on Mon 51810 1
...at data,presented recently at the 17th Annual Meet...iology demonstrate that the Genous Bio-engineered ...eluting stents., Presented by Federico Piscione, ...fessor with the Federico II University of Naples,s...dicine and Cardiovascular,Sciences, the data were ...
...ion Application currently u...erapeutics, Inc. (CTI),(Nasdaq: CTIC ; MTA) today...domized phase III trial comparing OPAXIO(TM) (pacl...orelbine for the treatment of PS 2,(performance st...ll cell,lung cancer (NSCLC) in the Journal of Thor...
Other Medicine Technology:Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 2Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5
...ested Timeter® Classic Flowmeters demonstrates...oviders and patients alike. You can see it in the ... can see it in the performance, year after year. E...d and engineered to the highest standards of perfo...
Soft-Touch Timeter® 15 LPM Dual Oxygen Flowmeter w/Y Bar & 2 Power Take Off
Soft-Touch Timeter® 15 LPM Dual Oxygen Flowmeter w/T Bar
Soft-Touch Timeter® 8 LPM Flowmeter
Medicine Products: